LRRK2 and Parkinson disease: The fact that the pathogenic mutations of LRRK2 uniformly increase substrate phosphorylation of LRRK2 strongly suggests that it is the increase in substrate phosphorylation that leads to neurodegeneration in LRRK2-associated PD.